ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $695,000 | +176.9% | 4,000 | +100.0% | 0.43% | +154.2% |
| Q2 2021 | $251,000 | -38.3% | 2,000 | -33.3% | 0.17% | -35.1% |
| Q1 2021 | $407,000 | +6.0% | 3,000 | 0.0% | 0.26% | +6.6% |
| Q4 2020 | $384,000 | +70.7% | 3,000 | +50.0% | 0.24% | +39.7% |
| Q3 2020 | $225,000 | -60.7% | 2,000 | -66.7% | 0.17% | -64.6% |
| Q2 2020 | $572,000 | – | 6,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |